Welcome to Kareus Therapeutics
Kareus Therapeutics is a biopharmaceutical company that discovers and develops novel small molecules as mono- or combination therapy for unmet treatment of age-related and chronic diseases. Our core expertise and current focus is on diseases of Central Nervous System, Diabetes and Chronic Pain.
Our discovery strategy is to target molecular and gene expression pathways using proprietary chemistry and biology platforms and generate drug candidates with distinct product profile. Kareus’ scientific team’s proven track record and recognized leadership helps propel molecules from exploratory through milestone discovery phases in a time and cost effective manner.
- Key features of our discovery strategy include
- Differentiated Product Profile - We strive to achieve product profile that can differentiate itself in the market place as well as be complementary to standard of care.
- Leveraging Global Networks - We maximize our investments by using a global networks of high quality preferred CRO’s.
- Strategic Partnerships - Our business strategy is to form early strategic alliances with pharmaceutical companies with complementary skills to maximize business and therapeutic potential of our molecules.